In The Press
All Access with Andy Garcia features Sunstone Therapies’ approach to psychedelic-assisted therapy
Public Television audiences will gain a closer look at psychedelic-assisted therapy, an emerging area in mental health treatments, and how it is being implemented within structured clinical care in an upcoming segment of All Access with Andy Garcia.
Sunstone Therapies Launches Clinical Study in Maryland on Group MDMA-Assisted Therapy for Veterans with PTSD
Sunstone Therapies has launched a new clinical trial evaluating group MDMA-assisted therapy for veterans living with PTSD. Supported by funding from the State of Maryland and Reason for Hope, the study will compare individual and group therapy models to assess safety, feasibility, and scalability. The research aims to expand access to evidence-based mental health care for veterans while generating critical insights into how psychedelic-assisted therapy may be delivered more effectively in the future.
The Intersection of Mystery and Meaning: Dr. Manish Agrawal on the “Death And” Podcast
What happens when an oncologist and a mortician discuss the mystery of death? Dr. Manish Agrawal joins the Death And podcast to bridge the gap between clinical rigor and human mystery. From the "collusion of denial" to the "infinity" found between birth and death, discover how psychedelic-assisted care invites patients back into their own experience to find peace and connection.
Dr. Manish Agrawal Discusses the “Collusion of Denial” in Cancer Care on Great Day Washington
Dr. Manish Agrawal, CEO of Sunstone Therapies, joined Great Day Washington to discuss adjustment disorder—a common but frequently overlooked emotional response to serious illnesses like cancer, MS, and Parkinson’s. While modern medicine excels at treating physical symptoms, Dr. Agrawal highlights the "collusion of denial" that often leaves patients to navigate emotional upheaval in silence. Learn how Sunstone is addressing this critical gap through the REKINDLE Phase 2 study, an innovative clinical trial evaluating an investigational treatment for psychological distress in patients facing life-altering diagnoses.
National Geographic Health Highlights the Potential of Psilocybin in End-of-Life Cancer Care
National Geographic recently highlighted emerging research on psilocybin-assisted therapy for patients facing advanced cancer and end-of-life distress. The article explores how psychedelic-assisted therapy may help reduce depression, anxiety, and existential suffering when delivered within structured clinical settings.
Podcast | Dr. Manish Agrawal with Healing Cancer Journeys
Blending Science, Story, and the Human Side of Healing October, 2025 — Sunstone Therapies CEO Dr. Manish Agrawal joined Dan […]
Previous studies on DMT at Sunstone Therapies
Sunstone is pleased to begin enrollment of two clinical studies exploring the therapeutic potential of DMT (N,N-dimethyltryptamine) and its analogs.
Sunstone Therapies Announces Publication of Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with Cancer, in CANCER, the Journal of the American Cancer Society
June 16, 2025 | A new study conducted by Sunstone Therapies suggests that a single dose of psilocybin, combined with psychological support, can provide sustained relief from depression for some cancer patients.
Psychedelic Alpha on Manish Agrawal and Kim Roddy, cofounders of Sunstone
Sunstone cofounders spoke with Josh Hardman about what they've learned from delivering hundreds of psychedelic therapy sessions.
Manish Agrawal appointed to Maryland’s task force on Responsible Use of Natural Psychedelic Substances
Dr. Manish Agrawal appointed to serve on Maryland's Task Force on Responsible Use of Natural Psychedelic Substances.